Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries

Vaccine. 2011 May 31;29(24):4173-4. doi: 10.1016/j.vaccine.2011.03.008. Epub 2011 Apr 5.

Authors

Agnes Kisser¹, Ulrich Heininger, Vasee S Moorthy, Bartholomew D Akanmori, Odile Leroy

Affiliation

¹ European Vaccine Initiative, UniversitaetsKlinikum Heidelberg, Im Neuenheimer Feld 326, 69120 Heidelberg, Germany. agneskisser@euvaccine.eu

PMID: 21473949
DOI: 10.1016/j.vaccine.2011.03.008

No abstract available

MeSH terms

Clinical Trials as Topic*
Developing Countries
Humans
Vaccines / adverse effects*

Substances

Vaccines